257 related articles for article (PubMed ID: 16234329)
41. Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.
Krejci P; Masri B; Salazar L; Farrington-Rock C; Prats H; Thompson LM; Wilcox WR
J Biol Chem; 2007 Feb; 282(5):2929-36. PubMed ID: 17145761
[TBL] [Abstract][Full Text] [Related]
42. Integrins and cell signaling in chondrocytes.
Loeser RF
Biorheology; 2002; 39(1-2):119-24. PubMed ID: 12082274
[TBL] [Abstract][Full Text] [Related]
43. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes.
Kajitani N; Hisaoka-Nakashima K; Okada-Tsuchioka M; Hosoi M; Yokoe T; Morioka N; Nakata Y; Takebayashi M
J Neurochem; 2015 Oct; 135(1):27-37. PubMed ID: 26183033
[TBL] [Abstract][Full Text] [Related]
45. Sur8/Shoc2 involves both inhibition of differentiation and maintenance of self-renewal of neural progenitor cells via modulation of extracellular signal-regulated kinase signaling.
Moon BS; Kim HY; Kim MY; Yang DH; Lee JM; Cho KW; Jung HS; Choi KY
Stem Cells; 2011 Feb; 29(2):320-31. PubMed ID: 21732489
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.
Hu P; Huang BY; Xia X; Xuan Q; Hu B; Qin YH
J Recept Signal Transduct Res; 2016; 36(2):213-9. PubMed ID: 26459742
[TBL] [Abstract][Full Text] [Related]
47. JNK/ERK/FAK mediate promigratory actions of basic fibroblast growth factor in astrocytes via CCL2 and COX2.
Lichtenstein MP; Madrigal JL; Pujol A; Galea E
Neurosignals; 2012; 20(2):86-102. PubMed ID: 22189091
[TBL] [Abstract][Full Text] [Related]
48. Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts.
Lenz A; Bennett M; Skelton WP; Vesely DL
Pediatr Res; 2010 Nov; 68(5):405-8. PubMed ID: 20613683
[TBL] [Abstract][Full Text] [Related]
49. Regulation of sprouty expression by PLCgamma and calcium-dependent signals.
Abe M; Naski MC
Biochem Biophys Res Commun; 2004 Oct; 323(3):1040-7. PubMed ID: 15381104
[TBL] [Abstract][Full Text] [Related]
50. [Chondrocyte metabolism may be regulated through the interaction with the extracellular matrix].
Fukui N
Clin Calcium; 2011 Jun; 21(6):861-70. PubMed ID: 21628801
[TBL] [Abstract][Full Text] [Related]
51. The downstream RAF-1 signaling of fibroblast growth factor-23 participates in the osteogenetic effect caused by C-type natriuretic peptide in vitro.
Li RX; Chen WX; Liu HH; Fan GZ; Qiu Z; Jiang Q; Wu YF; Zhang DD; Luo HH; Hu P
Adv Med Sci; 2021 Mar; 66(1):206-214. PubMed ID: 33735829
[TBL] [Abstract][Full Text] [Related]
52. Effect of C-type natriuretic peptide (CNP) on water channel aquaporin-4 (AQP4) expression in cultured astrocytes.
Miyajima M; Arai H; Okuda O; Hishii M; Nakanishi H; Ishii H; Sato K
Brain Res Mol Brain Res; 2004 Mar; 122(2):109-15. PubMed ID: 15010203
[TBL] [Abstract][Full Text] [Related]
53. Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis.
Bükülmez H; Khan F; Bartels CF; Murakami S; Ortiz-Lopez A; Sattar A; Haqqi TM; Warman ML
Arthritis Rheumatol; 2014 Jan; 66(1):78-89. PubMed ID: 24449577
[TBL] [Abstract][Full Text] [Related]
54. C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis.
Woods A; Khan S; Beier F
Endocrinology; 2007 Oct; 148(10):5030-41. PubMed ID: 17640987
[TBL] [Abstract][Full Text] [Related]
55. Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP.
Mericq V; Uyeda JA; Barnes KM; De Luca F; Baron J
Pediatr Res; 2000 Feb; 47(2):189-93. PubMed ID: 10674345
[TBL] [Abstract][Full Text] [Related]
56. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide.
Khambata RS; Panayiotou CM; Hobbs AJ
Br J Pharmacol; 2011 Sep; 164(2b):584-97. PubMed ID: 21457229
[TBL] [Abstract][Full Text] [Related]
57. Chondrocyte-matrix attachment complexes mediate survival and differentiation.
Svoboda KK
Microsc Res Tech; 1998 Oct; 43(2):111-22. PubMed ID: 9822998
[TBL] [Abstract][Full Text] [Related]
58. Effect of PPADS on achondroplasic chondrocytes: inhibition of FGF receptor type 3 over-activity.
Guzmán-Aránguez A; Crooke A; Yayon A; Pintor J
Eur J Pharmacol; 2008 Apr; 584(1):72-7. PubMed ID: 18336810
[TBL] [Abstract][Full Text] [Related]
59. C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling.
Zhang DD; Wu YF; Chen WX; Xu Y; Liu SY; Luo HH; Jiang GM; Wu Y; Hu P
Exp Mol Med; 2019 Jul; 51(7):1-18. PubMed ID: 31263178
[TBL] [Abstract][Full Text] [Related]
60. Effect of CCN2 on FGF2-induced proliferation and MMP9 and MMP13 productions by chondrocytes.
Nishida T; Kubota S; Aoyama E; Janune D; Maeda A; Takigawa M
Endocrinology; 2011 Nov; 152(11):4232-41. PubMed ID: 21914781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
